Key autoantigens in SLE
Open Access
- 18 May 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (8) , 975-982
- https://doi.org/10.1093/rheumatology/keh688
Abstract
Murine and human systemic lupus erythematosus (SLE, lupus) is characterized by the appearance of autoantibodies directed to nuclear and cell membrane phospholipid components. Some functionally related nucleic acid-containing macromolecules such as chromatin or ribonucleoprotein particles are specifically targeted both by autoantibodies and T cells involved in lupus pathogenesis. In the last decade, the identification of target structures has strongly improved diagnostic tools. Furthermore, characterization of autoantigens has provided insight into pathogenic mechanisms to understand why these autoantigens are recognized in SLE. However, the recognition of autoantigens and a stable immune response towards these specificities requires the coincidence of several events (such as environmental triggers in the external world) plus abnormalities in genetically susceptible organisms that modify normal immune responses. Furthermore, the persistence of the autoantibody response in lupus long after the initial trigger suggests that endogenous autoantigens (from the internal world) are important in sustaining the ongoing immune response. Once the critical threshold is breached, there is a failure of the immune system to down-regulate normal immune responses which thus become abnormal and persistently autoreactive [1]. The importance of different events and genes that initiate and/or maintain the autoimmune response may vary from patient to patient, all resulting in the characteristic autoimmune features and pathology of this systemic autoimmune disease.Keywords
This publication has 95 references indexed in Scilit:
- Improved Serological Differentiation between Systemic Lupus Erythematosus and Mixed Connective Tissue Disease by Use of an SmD3 Peptide-Based ImmunoassayClinical and Vaccine Immunology, 2005
- Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐Sm and anti‐RNP antibody testsArthritis Care & Research, 2004
- Familiality and co‐occurrence of clinical features of systemic lupus erythematosusArthritis & Rheumatism, 2002
- Reactivities to the Sm Autoantigenic Complex and the Synthetic SmD1-aa83–119 Peptide in Systemic Lupus Erythematosus and other Autoimmune DiseasesJournal of Autoimmunity, 2001
- Monoclonal Antibodies Derived from BALB/c Mice Immunized with Apoptotic Jurkat T cells Recognize Known AutoantigensJournal of Autoimmunity, 2001
- Diverse Antibody Recognition Patterns of the Multiple Sm-D Antigen PolypeptidesClinical Immunology, 1999
- Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.Journal of Clinical Investigation, 1996
- Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRLIpr/lprantibodiesClinical and Experimental Immunology, 1994
- Immune Response to Different Sequences of the EBNA I Molecule in Epstein-Barr Virus-Related Disorders and in Autoimmune DiseasesJournal of Autoimmunity, 1994
- Cross-reactivity of the BB′ subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptidesClinical Immunology and Immunopathology, 1992